(MAC) Macerich - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5543821012
Stock:
Total Rating 36
Risk 40
Buy Signal -0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 37.1% |
| Relative Tail Risk | -2.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -11.75 |
| Character TTM | |
|---|---|
| Beta | 1.202 |
| Beta Downside | 1.830 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.56% |
| CAGR/Max DD | 0.60 |
EPS (Earnings per Share)
Revenue
Description: MAC Macerich
Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns 39 million square feet of real estate, consisting primarily of interests in 38 retail centers. Macerich is firmly dedicated to advancing environmental goals, social good and sound corporate governance.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -197.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 16.32 > 1.0 |
| NWC/Revenue: -58.49% < 20% (prev -35.44%; Δ -23.05% < -1%) |
| CFO/TA 0.19 > 3% & CFO 292.5m > Net Income -197.1m |
| Net Debt (-43.0m) to EBITDA (637.8m): -0.07 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (256.6m) vs 12m ago 8.45% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 20.11% > 50% (prev 10.72%; Δ 9.39% > 0%) |
| Interest Coverage Ratio: 0.96 > 6 (EBITDA TTM 637.8m / Interest Expense TTM 283.5m) |
Altman Z'' -10.18
| A: -0.39 (Total Current Assets 102.6m - Total Current Liabilities 695.7m) / Total Assets 1.52b |
| B: -2.45 (Retained Earnings -3.72b / Total Assets 1.52b) |
| C: 0.05 (EBIT TTM 272.3m / Avg Total Assets 5.04b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 1.52b) |
| Altman-Z'' Score: -10.18 = D |
Beneish M -4.00
| DSRI: 0.34 (Receivables 59.6m/157.2m, Revenue 1.01b/918.2m) |
| GMI: 0.56 (GM 95.40% / 53.14%) |
| AQI: 0.94 (AQ_t 0.89 / AQ_t-1 0.95) |
| SGI: 1.10 (Revenue 1.01b / 918.2m) |
| TATA: -0.32 (NI -197.1m - CFO 292.5m) / TA 1.52b) |
| Beneish M-Score: -4.26 (Cap -4..+1) = AAA |
What is the price of MAC shares?
As of February 24, 2026, the stock is trading at USD 20.22 with a total of 1,923,103 shares traded.
Over the past week, the price has changed by +7.61%, over one month by +10.19%, over three months by +23.52% and over the past year by +6.05%.
Over the past week, the price has changed by +7.61%, over one month by +10.19%, over three months by +23.52% and over the past year by +6.05%.
Is MAC a buy, sell or hold?
Macerich has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold MAC.
- StrongBuy: 4
- Buy: 1
- Hold: 8
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the MAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.1 | -0.4% |
| Analysts Target Price | 20.1 | -0.4% |
MAC Fundamental Data Overview February 21, 2026
P/E Forward = 500.0
P/S = 4.819
P/B = 1.889
P/EG = -485.0
Revenue TTM = 1.01b USD
EBIT TTM = 272.3m USD
EBITDA TTM = 637.8m USD
Long Term Debt = 5.08b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 5.15b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -43.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.40b USD (5.30b + Debt 5.15b - CCE 43.0m)
Interest Coverage Ratio = 0.96 (Ebit TTM 272.3m / Interest Expense TTM 283.5m)
EV/FCF = 34.98x (Enterprise Value 10.40b / FCF TTM 297.4m)
FCF Yield = 2.86% (FCF TTM 297.4m / Enterprise Value 10.40b)
FCF Margin = 29.33% (FCF TTM 297.4m / Revenue TTM 1.01b)
Net Margin = -19.44% (Net Income TTM -197.1m / Revenue TTM 1.01b)
Gross Margin = unknown ((Revenue TTM 1.01b - Cost of Revenue TTM 46.6m) / Revenue TTM)
Tobins Q-Ratio = 6.86 (Enterprise Value 10.40b / Total Assets 1.52b)
Interest Expense / Debt = 1.36% (Interest Expense 69.8m / Debt 5.15b)
Taxrate = 21.0% (US default 21%)
NOPAT = 215.1m (EBIT 272.3m * (1 - 21.00%))
Current Ratio = 0.15 (Total Current Assets 102.6m / Total Current Liabilities 695.7m)
Debt / Equity = 2.05 (Debt 5.15b / totalStockholderEquity, two quarters ago 2.51b)
Debt / EBITDA = -0.07 (Net Debt -43.0m / EBITDA 637.8m)
Debt / FCF = -0.14 (Net Debt -43.0m / FCF TTM 297.4m)
Total Stockholder Equity = 2.63b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.91% (Net Income -197.1m / Total Assets 1.52b)
RoE = -7.50% (Net Income TTM -197.1m / Total Stockholder Equity 2.63b)
RoCE = 3.53% (EBIT 272.3m / Capital Employed (Equity 2.63b + L.T.Debt 5.08b))
RoIC = 2.76% (NOPAT 215.1m / Invested Capital 7.80b)
WACC = 5.77% (E(5.30b)/V(10.45b) * Re(10.34%) + D(5.15b)/V(10.45b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.05%
[DCF Debug] Terminal Value 86.54% ; FCFF base≈290.7m ; Y1≈296.7m ; Y5≈327.3m
Fair Price DCF = 38.20 (EV 9.74b - Net Debt -43.0m = Equity 9.78b / Shares 256.1m; r=5.90% [WACC]; 5y FCF grow 1.91% → 2.90% )
EPS Correlation: 4.20 | EPS CAGR: 4.68% | SUE: 0.05 | # QB: 0
Revenue Correlation: 76.92 | Revenue CAGR: 5.23% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.10 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-12-31): EPS=-0.17 | Chg30d=+0.027 | Revisions Net=+1 | Growth EPS=+42.4% | Growth Revenue=-7.0%
EPS next Year (2027-12-31): EPS=-0.03 | Chg30d=+0.045 | Revisions Net=+1 | Growth EPS=+80.9% | Growth Revenue=+2.1%
P/S = 4.819
P/B = 1.889
P/EG = -485.0
Revenue TTM = 1.01b USD
EBIT TTM = 272.3m USD
EBITDA TTM = 637.8m USD
Long Term Debt = 5.08b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 5.15b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -43.0m USD (from netDebt column, last quarter)
Enterprise Value = 10.40b USD (5.30b + Debt 5.15b - CCE 43.0m)
Interest Coverage Ratio = 0.96 (Ebit TTM 272.3m / Interest Expense TTM 283.5m)
EV/FCF = 34.98x (Enterprise Value 10.40b / FCF TTM 297.4m)
FCF Yield = 2.86% (FCF TTM 297.4m / Enterprise Value 10.40b)
FCF Margin = 29.33% (FCF TTM 297.4m / Revenue TTM 1.01b)
Net Margin = -19.44% (Net Income TTM -197.1m / Revenue TTM 1.01b)
Gross Margin = unknown ((Revenue TTM 1.01b - Cost of Revenue TTM 46.6m) / Revenue TTM)
Tobins Q-Ratio = 6.86 (Enterprise Value 10.40b / Total Assets 1.52b)
Interest Expense / Debt = 1.36% (Interest Expense 69.8m / Debt 5.15b)
Taxrate = 21.0% (US default 21%)
NOPAT = 215.1m (EBIT 272.3m * (1 - 21.00%))
Current Ratio = 0.15 (Total Current Assets 102.6m / Total Current Liabilities 695.7m)
Debt / Equity = 2.05 (Debt 5.15b / totalStockholderEquity, two quarters ago 2.51b)
Debt / EBITDA = -0.07 (Net Debt -43.0m / EBITDA 637.8m)
Debt / FCF = -0.14 (Net Debt -43.0m / FCF TTM 297.4m)
Total Stockholder Equity = 2.63b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.91% (Net Income -197.1m / Total Assets 1.52b)
RoE = -7.50% (Net Income TTM -197.1m / Total Stockholder Equity 2.63b)
RoCE = 3.53% (EBIT 272.3m / Capital Employed (Equity 2.63b + L.T.Debt 5.08b))
RoIC = 2.76% (NOPAT 215.1m / Invested Capital 7.80b)
WACC = 5.77% (E(5.30b)/V(10.45b) * Re(10.34%) + D(5.15b)/V(10.45b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.05%
[DCF Debug] Terminal Value 86.54% ; FCFF base≈290.7m ; Y1≈296.7m ; Y5≈327.3m
Fair Price DCF = 38.20 (EV 9.74b - Net Debt -43.0m = Equity 9.78b / Shares 256.1m; r=5.90% [WACC]; 5y FCF grow 1.91% → 2.90% )
EPS Correlation: 4.20 | EPS CAGR: 4.68% | SUE: 0.05 | # QB: 0
Revenue Correlation: 76.92 | Revenue CAGR: 5.23% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.10 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-12-31): EPS=-0.17 | Chg30d=+0.027 | Revisions Net=+1 | Growth EPS=+42.4% | Growth Revenue=-7.0%
EPS next Year (2027-12-31): EPS=-0.03 | Chg30d=+0.045 | Revisions Net=+1 | Growth EPS=+80.9% | Growth Revenue=+2.1%